Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Vizgen webinar: spatial relationships in Developmental Biology
Nov 21, 2023
MERFISH integrates spatial transcriptomics technology with high resolution spatial imaging, In this webinar we will...
Nov 14, 2023
The xCELLigence RTCA eSight enables simultaneous real time biosensor impedance-based and...
NanoCellect webinar: Plant Potential - Gentle Cell Sorting for Enhanced Plant Biology Workflows
Nov 3, 2023
Gentle cell sorting is a useful tool to increase the efficiency of plant biology workflows that include gene...
RareCyte webinar recording: Use of open-source software for quantitative analysis of multiplex image
Nov 1, 2023
In this webinar, Dr. McArdle describes how multiplex immunostaining is a key method for understanding spatial context...
NanoCellect Webinar: Enhancing Genomics Sequencing Data with Gentle Cell Sorting
Oct 6, 2023
With the WOLF Cell Sorter, researchers can easily isolate viable cell samples for genomics workflows before sequencing....
WEBINAR: In Vivo Optical Imaging, unique capabilities and expanding range of applications
Oct 4, 2023
In this educational webinar presented by Andrew D.G. Van Praagh we will discuss the unique strengths of BLI and FLI,...
Cytek webinar recording : introducing the new Autofluorescence (AF) Explorer in Spectroflo 3.2.1
Sep 25, 2023
In this webinar, Cytek will be covering the new features introduced in the newest SpectroFlo 3.2.1 software release and...
Webinar recording: Introducing MARS Platform for gentle cell separation
Sep 6, 2023
Join us for a webinar where we will introduce the new MARS Platform by Applied Cells, a...
Assessment of CAR T Cell killing capacity against solid tumors-Thursday, October 20, 2016, 5 pm CEST
Oct 13, 2016
Nabil Ahmed, M.D., M.P.H. Associate Professor of Pediatrics, Baylor College of Medicine (USA).
Robust CAR design and sensitive yet realistic functional testing will be required in order to improve the efficacy of CAR T cell therapies targeting solid tumors. We have used the xCELLigence Real-Time Cell Analyzer as a high-throughput platform to test multiple CAR components including extracellular domains (including bi-specifics), signaling endo-domains, as well as next-generation CAR T cell products that are inherently resistant to checkpoint blockade. This platform has proven very sensitive to subtle yet longitudinally meaningful differences in CAR design, and has made it possible to evaluate T cell products in a "stress test" that is more representative of early phase trial requirements.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
